A phase III study of standard fractionation radiotherapy with concurrent high-dose cisplatin versus accelerated fractionation radiotherapy (RT) with panitumumab in patients with locally advanced stage III and IV squamous cell carcinoma of the head and neck (SCCHN) (NCIC Clinical Trials Group HN.6). Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Waldron, John N
  • Parulekar, Wendy
  • O'Sullivan, Brian
  • Chen, Bingshu E
  • Montenegro, Alexander
  • Nabid, Abdenour
  • Winquist, Eric
  • Wright, James
  • Hay, John
  • Ringash, Jolie
  • Martino, Rosemary
  • Johnson, Ana
  • Liu, Geoffrey
  • Breen, Stephen
  • Gilbert, Ralph William
  • Shenouda, George
  • Siu, Lillian L

publication date

  • May 20, 2012